D. E. Shaw & Co., Inc. Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $136,647 - $206,304	-2,100 Reduced 5.25%	37,900 $3.25 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $408,600 - $576,500	10,000 Added 33.33%	40,000 $2.18 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $1.19 Million - $2.01 Million	30,000 New	30,000 $1.31 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.